TrialDiabetes, obesity & metabolism2019

Model-based characterization of the relationship between dapagliflozin systemic exposure and HbA1c response in patients with type 1 diabetes mellitus.

Joanna Parkinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.